EPC
EPC
Edgewell Personal Care CompanyIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $519.5M ▲ | $179.5M ▲ | $-10.6M ▲ | -2.04% ▲ | $-0.23 ▲ | $65.3M ▲ |
| Q1-2026 | $422.8M ▼ | $161.8M ▼ | $-65.7M ▼ | -15.54% ▼ | $-1.41 ▼ | $3.7M ▲ |
| Q4-2025 | $537.2M ▼ | $244.9M ▲ | $-30.6M ▼ | -5.7% ▼ | $-0.66 ▼ | $-15.2M ▼ |
| Q3-2025 | $627.2M ▲ | $214.8M ▲ | $29.1M ▲ | 4.64% ▼ | $0.61 ▲ | $78.7M ▼ |
| Q2-2025 | $580.7M | $197.3M | $29M | 4.99% | $0.6 | $83.3M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $299.7M ▲ | $3.53B ▼ | $2.09B ▼ | $1.45B ▼ |
| Q1-2026 | $223.3M ▼ | $3.77B ▲ | $2.28B ▲ | $1.49B ▼ |
| Q4-2025 | $225.7M ▲ | $3.76B ▼ | $2.2B ▼ | $1.55B ▼ |
| Q3-2025 | $199.6M ▲ | $3.79B ▲ | $2.23B ▼ | $1.57B ▲ |
| Q2-2025 | $170.1M | $3.77B | $2.26B | $1.51B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $4M ▲ | $54.3M ▲ | $325M ▲ | $-300.8M ▼ | $76.4M ▲ | $40.3M ▲ |
| Q1-2026 | $-29.2M ▲ | $-125.9M ▼ | $-9.9M ▲ | $133.4M ▲ | $-2.4M ▼ | $-137.5M ▼ |
| Q4-2025 | $-30.6M ▼ | $74.1M ▼ | $-27.6M ▼ | $-19.1M ▲ | $26.1M ▼ | $46.5M ▼ |
| Q3-2025 | $29.1M ▲ | $114.8M ▲ | $-12.3M ▲ | $-83.4M ▼ | $29.5M ▲ | $99.3M ▲ |
| Q2-2025 | $29M | $45.1M | $-17.3M | $-37.4M | $-5.4M | $28M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
Razors and blades | $290.00M ▲ | $290.00M ▲ | $260.00M ▼ | $270.00M ▲ |
Shaving gels and creams | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $20.00M ▼ |
Sun care products | $180.00M ▲ | $70.00M ▼ | $60.00M ▼ | $150.00M ▲ |
Wipes and other skin care products | $0 ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Infant Care and Other Products | $50.00M ▲ | $50.00M ▲ | $0 ▼ | $0 ▲ |
Skin Care Products | $20.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Tampons Pads and Liners | $70.00M ▲ | $70.00M ▲ | $0 ▼ | $0 ▲ |
Revenue by Geography
| Region | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
NonUS | $280.00M ▲ | $260.00M ▼ | $230.00M ▼ | $250.00M ▲ |
UNITED STATES | $340.00M ▲ | $280.00M ▼ | $190.00M ▼ | $270.00M ▲ |
Q2 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Edgewell Personal Care Company's financial evolution and strategic trajectory over the past five years.
Edgewell benefits from a stable revenue base, a portfolio of recognizable global brands, and a solid liquidity position. Its history of positive retained earnings and investment in R&D shows a capacity to generate profits over time and a willingness to reinvest in the business. The company’s presence across shaving, sun and skin care, and grooming, along with growing DTC and premium brand exposure, provides diversification and multiple avenues for growth and repositioning.
The most pressing risks are the sharp recent deterioration in profitability and cash generation, coupled with a gradual increase in leverage and a lower cash cushion than in the past. Heavy reliance on intangible assets means that underperformance could lead to impairments, while intense competition, shifting consumer preferences, and retailer pressure make it costly to defend and grow share. Continued high capital spending and shareholder returns, if not matched by a recovery in earnings and free cash flow, could further strain the balance sheet over time.
Edgewell appears to be in the middle of a strategic transition: refocusing on its core categories, leaning into innovation, premiumization, and digital channels, and trying to modernize its portfolio while operating in mature, highly competitive markets. If its innovation pipeline and brand strategy succeed, there is room for margins and cash flow to recover from current depressed levels. If not, the combination of modest top‑line growth, margin pressure, and rising leverage could keep financial performance subdued. Overall, the outlook hinges on the company’s execution in turning its brand and innovation strengths into tangible improvements in profitability and cash flow.
About Edgewell Personal Care Company
https://edgewell.comEdgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $519.5M ▲ | $179.5M ▲ | $-10.6M ▲ | -2.04% ▲ | $-0.23 ▲ | $65.3M ▲ |
| Q1-2026 | $422.8M ▼ | $161.8M ▼ | $-65.7M ▼ | -15.54% ▼ | $-1.41 ▼ | $3.7M ▲ |
| Q4-2025 | $537.2M ▼ | $244.9M ▲ | $-30.6M ▼ | -5.7% ▼ | $-0.66 ▼ | $-15.2M ▼ |
| Q3-2025 | $627.2M ▲ | $214.8M ▲ | $29.1M ▲ | 4.64% ▼ | $0.61 ▲ | $78.7M ▼ |
| Q2-2025 | $580.7M | $197.3M | $29M | 4.99% | $0.6 | $83.3M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $299.7M ▲ | $3.53B ▼ | $2.09B ▼ | $1.45B ▼ |
| Q1-2026 | $223.3M ▼ | $3.77B ▲ | $2.28B ▲ | $1.49B ▼ |
| Q4-2025 | $225.7M ▲ | $3.76B ▼ | $2.2B ▼ | $1.55B ▼ |
| Q3-2025 | $199.6M ▲ | $3.79B ▲ | $2.23B ▼ | $1.57B ▲ |
| Q2-2025 | $170.1M | $3.77B | $2.26B | $1.51B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $4M ▲ | $54.3M ▲ | $325M ▲ | $-300.8M ▼ | $76.4M ▲ | $40.3M ▲ |
| Q1-2026 | $-29.2M ▲ | $-125.9M ▼ | $-9.9M ▲ | $133.4M ▲ | $-2.4M ▼ | $-137.5M ▼ |
| Q4-2025 | $-30.6M ▼ | $74.1M ▼ | $-27.6M ▼ | $-19.1M ▲ | $26.1M ▼ | $46.5M ▼ |
| Q3-2025 | $29.1M ▲ | $114.8M ▲ | $-12.3M ▲ | $-83.4M ▼ | $29.5M ▲ | $99.3M ▲ |
| Q2-2025 | $29M | $45.1M | $-17.3M | $-37.4M | $-5.4M | $28M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
Razors and blades | $290.00M ▲ | $290.00M ▲ | $260.00M ▼ | $270.00M ▲ |
Shaving gels and creams | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $20.00M ▼ |
Sun care products | $180.00M ▲ | $70.00M ▼ | $60.00M ▼ | $150.00M ▲ |
Wipes and other skin care products | $0 ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Infant Care and Other Products | $50.00M ▲ | $50.00M ▲ | $0 ▼ | $0 ▲ |
Skin Care Products | $20.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Tampons Pads and Liners | $70.00M ▲ | $70.00M ▲ | $0 ▼ | $0 ▲ |
Revenue by Geography
| Region | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
NonUS | $280.00M ▲ | $260.00M ▼ | $230.00M ▼ | $250.00M ▲ |
UNITED STATES | $340.00M ▲ | $280.00M ▼ | $190.00M ▼ | $270.00M ▲ |
Q2 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Edgewell Personal Care Company's financial evolution and strategic trajectory over the past five years.
Edgewell benefits from a stable revenue base, a portfolio of recognizable global brands, and a solid liquidity position. Its history of positive retained earnings and investment in R&D shows a capacity to generate profits over time and a willingness to reinvest in the business. The company’s presence across shaving, sun and skin care, and grooming, along with growing DTC and premium brand exposure, provides diversification and multiple avenues for growth and repositioning.
The most pressing risks are the sharp recent deterioration in profitability and cash generation, coupled with a gradual increase in leverage and a lower cash cushion than in the past. Heavy reliance on intangible assets means that underperformance could lead to impairments, while intense competition, shifting consumer preferences, and retailer pressure make it costly to defend and grow share. Continued high capital spending and shareholder returns, if not matched by a recovery in earnings and free cash flow, could further strain the balance sheet over time.
Edgewell appears to be in the middle of a strategic transition: refocusing on its core categories, leaning into innovation, premiumization, and digital channels, and trying to modernize its portfolio while operating in mature, highly competitive markets. If its innovation pipeline and brand strategy succeed, there is room for margins and cash flow to recover from current depressed levels. If not, the combination of modest top‑line growth, margin pressure, and rising leverage could keep financial performance subdued. Overall, the outlook hinges on the company’s execution in turning its brand and innovation strengths into tangible improvements in profitability and cash flow.

CEO
Rod R. Little
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-07-01 | Forward | 1349:1000 |
ETFs Holding This Stock
Summary
Showing Top 3 of 175
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
UBS
Neutral
Wells Fargo
Overweight
Barclays
Equal Weight
Morgan Stanley
Equal Weight
RBC Capital
Outperform
Canaccord Genuity
Buy
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:7.67M
Value:$134.44M
BLACKROCK, INC.
Shares:7.36M
Value:$128.98M
BRANDES INVESTMENT PARTNERS, LP
Shares:6.72M
Value:$117.75M
Summary
Showing Top 3 of 374

